Updated work programme of the European Pharmacopoeia

Size: px
Start display at page:

Download "Updated work programme of the European Pharmacopoeia"

Transcription

1 Pharmeuropa Useful information March Updated work programme of the European Pharmacopoeia (November 2017) The following items have been added to or deleted from the work programme during the 159 th session of the European Pharmacopoeia Commission. Consult the Knowledge Database to follow the work on individual texts. Interested parties are invited to contact the EDQM via the HelpDesk with a view to participating in the work on items of interest. TEXTS TO BE REVISED Methods of analysis Microbiological examination of cell-based preparations Materials and Containers Clarification of the section dealing with method suitability Glass containers for pharmaceutical use Review of the quality of water used in the tests General monographs Products of fermentation (1468) Vaccines for veterinary use (0062) Vaccines Avian infectious bronchitis vaccine (live) (0442) Avian infectious bursal disease vaccine (live) (0587) Avian infectious encephalomyelitis vaccine (live) (0588) Avian infectious laryngotracheitis vaccine (live) (1068) Avian viral tenosynovitis vaccine (live) (1956) Bovine parainfluenza virus vaccine (live) (1176) Bovine respiratory syncytial virus vaccine (live) (1177) Canine adenovirus vaccine (live) (1951) Canine distemper vaccine (live) (0448) Canine parainfluenza virus vaccine (live) (1955) Alerting to the risk of using histidine-containing raw materials in a fermentation process ; revision to add that antibiotic use during production of IVMPs should be justified

2 2 Pharmeuropa Useful information March 2018 Canine parvovirosis vaccine (live) (0964) Distemper vaccine (live) for mustelids (0449) Duck plague vaccine (live) (1938) Duck viral hepatitis type I vaccine (live) (1315) Feline calicivirosis vaccine (live) (1102) Feline infectious enteritis (feline panleucopenia) vaccine (live) (0251) Feline viral rhinotracheitis vaccine (live) (1206) Fowl-pox vaccine (live) (0649) Infectious bovine rhinotracheitis vaccine (live) (0696) Infectious chicken anaemia vaccine (live) (2038) Marek s disease vaccine (live) (0589) Myxomatosis vaccine (live) for rabbits (1943) Newcastle disease vaccine (live) (0450) Swine-fever vaccine (live, prepared in cell cultures), classical (0065) Tetanus vaccine (adsorbed) (0452) Tetanus vaccine for veterinary use (0697) Turkey infectious rhinotracheitis vaccine (live) (2461) Herbal drugs Quillaia bark (1843) Monographs Betamethasone (0312) Betamethasone acetate (0975) Betamethasone dipropionate (0809) Betamethasone sodium phosphate (0810) Betamethasone valerate (0811) Castor oil, hydrogenated (1497) Chlorpropamide (1087) Dexamethasone (0388) Dexamethasone acetate (0548) Dexamethasone sodium phosphate (0549) Dextromethorphan hydrobromide (0020) Deletion of test for irreversibility of the tetanus toxoid Revision to delete test for irreversibility of the tetanus toxoid, to harmonise the testing method for absence of toxin with monograph Tetanus vaccine (adsorbed) (0452) and to consider harmonisation of the requirements for the toxoid Update of HPTLC method for identification Revision of Definition Addition of a test for levomethorphan

3 Pharmeuropa Useful information March Glipizide (0906) Glycerol monostearate (0495) Haemodialysis, solutions for (0128) Haemofiltration and haemodiafiltration, solutions for (0861) Hard fat (0462) Hard fat with additives (2731) Hydrochloric acid, concentrated (0002) Levomenthol (0619) Menthol, racemic (0623) Methylprednisolone (0561) Nicardipine hydrochloride (2776) Pentobarbital (0200) Pentobarbital sodium (0419) Peritoneal dialysis, solutions for (0862) Prednicarbate (1467) Prednisolone (0353) Prednisolone acetate (0734) Prednisone (0354) Revision of test for free glycerol (symmetry factor) and to allow use of two 30 cm columns instead of one 60 cm column Revision of Definition (replacement of hydrogenated by saturated) and Identification sections Revision of Definition (replacement of hydrogenated by saturated) and Identification sections Revision of test for residue on evaporation Revision of test for related substances Revision of test for related substances Following the adoption of a revised draft at the 159 th Commission session (November 2017), the monograph needs to be further revised: I) Characters: solubility section to be revised to include at least an alcohol and a lipophilic solvent. II) Identification: update of the whole section, consider the introduction of IR test and second identification series. III) Related substances consider tightening the impurity limits after having collected sufficient batch/stability data. Following the adoption of a revised draft at the 159 th Commission session (November 2017), the monograph needs to be further revised: I) Characters: solubility section to be revised to include at least an alcohol and a lipophilic solvent. II) Identification: update of the whole section, consider the introduction of IR test and second identification series. III) Appearance of solution: test to be added as the substance is used in injectable products. IV) Related substances: consider tightening the impurity limits after having collected sufficient batch/stability data.

4 4 Pharmeuropa Useful information March 2018 Rabeprazole sodium (2868) Remifentanil hydrochloride (2644) Sodium nitrite (1996) Sodium thiosulfate (0414) Squalane (1630) Triglycerides, medium-chain (0868) Urokinase (0695) Update of loss on drying test Evaluation of Loss on drying versus Water Monograph update Monograph update Revision of Identification Revision of hydroxyl value determination (analytical improvement) Deletion of rabbit pyrogen test

5 Pharmeuropa Useful information March ADDITIONS TO THE WORK PROGRAMME (new texts to be elaborated) Monocyte-activation test for vaccines containing inherently pyrogenic components Implementation of pharmacopoeial methods Cross validation N-Boc-O-dimethoxytrityl-O -nosyl-thymidine precursor for radiopharmaceutical preparations (3091) Erlotinib hydrochloride (3094) Eschscholzia herb (3088) (S)-3-(5-Formyl-4-methoxymethoxy-2-nitrophenyl)-2-(trityl-amino)-propionic acid tert-butyl ester precursor for radiopharmaceutical preparations (3093) Fulvestrant injection (3096) Helichrysi flos (3089) (2S)-O-(2 -O -Tosyloxyethyl)-N-trityl-tyrosine tert-butyl ester precursor for radiopharmaceutical preparations (3092) Vibriosis vaccine (inactivated) for sea bass (3090) Vincamine (1800) DELETIONS FROM THE WORK PROGRAMME (new texts or requests for revision) Brimonidine tartrate (2760) Sweet-fennel fruit oil (2808)

List of texts adopted at the November 2017 session of the European Pharmacopoeia Commission

List of texts adopted at the November 2017 session of the European Pharmacopoeia Commission Pharmeuropa Useful information February 2018 1 List of texts adopted at the November 2017 session of the European Pharmacopoeia Commission NEW TEXTS MONOGRAPHS Herbal drugs and herbal drug preparations

More information

Updated work programme of the European Pharmacopoeia

Updated work programme of the European Pharmacopoeia Pharmeuropa Useful information February 2017 1 Updated work programme of the European Pharmacopoeia (November 2016) The following items have been added to or deleted from the work programme during the

More information

ASEAN STANDARDS FOR ANIMAL VACCINES

ASEAN STANDARDS FOR ANIMAL VACCINES Adopted at the 40 th AMAF 11 October 2018 Ha Noi, Viet Nam ASEAN Cooperation in Food, Agriculture and Forestry ASEAN STANDARDS FOR ANIMAL VACCINES Third Edition Li v e s t o c k Publication Series No.2A

More information

The List is only for reference purpose and may not be used for License or other Statutory Clearance

The List is only for reference purpose and may not be used for License or other Statutory Clearance List of approved veterinary drugs and devices till 17.03.2015 A-List of Veterinary drugs Approved Sr. No. Drug Name Date of issue Nil Nil Nil B-List of Veterinary drugs registered-(finish Formulation)

More information

General concepts in the Ph. Eur.: theory and rationale

General concepts in the Ph. Eur.: theory and rationale General concepts in the Ph. Eur.: theory and rationale Cathie VIELLE Head of European Pharmacopoeia Department, EDQM / CoE 1 The structure of the Ph. Eur. General monographs Dosage form monographs General

More information

List of texts adopted at the November 2014 session of the European Pharmacopoeia Commission

List of texts adopted at the November 2014 session of the European Pharmacopoeia Commission Pharmeuropa Useful information January 2015 1 List of texts adopted at the November 2014 session of the European Pharmacopoeia Commission NEW TEXTS Radiopharmaceutical preparations and starting materials

More information

Topics covered by the talk

Topics covered by the talk 04/02/2016 Finished product monographs containing chemically defined active substances Dr Dirk Leutner Scientific Officer, European Pharmacopoeia Department European Directorate for the Quality of Medicines

More information

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe General Concepts in the European Pharmacopoeia Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe General notices Anne-Sophie Bouin, 28/10/09 2009 EDQM, Council of Europe, All

More information

Annex to Commission Decision of the Customs Union N 455 of 18 November 2010 CONSOLIDATED LIST OF DANGEROUS AND QUARANTINE ANIMAL DISEASES

Annex to Commission Decision of the Customs Union N 455 of 18 November 2010 CONSOLIDATED LIST OF DANGEROUS AND QUARANTINE ANIMAL DISEASES Annex to Commission Decision of the Customs Union N 455 of 18 November 2010 CONSOLIDATED LIST OF DANGEROUS AND QUARANTINE ANIMAL DISEASES Animal diseases require quarantine: Rift valley fever Foot and

More information

EDQM and European Pharmacopoeia: State-of-the-art Science for Tomorrow s Medicines

EDQM and European Pharmacopoeia: State-of-the-art Science for Tomorrow s Medicines EDQM and European Pharmacopoeia: State-of-the-art Science for Tomorrow s Medicines International Conference organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council

More information

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015 Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015 Dr. Susanne Keitel Director EDQM, Council of Europe Outline 1. The European Pharmacopoeia 2. The importance of

More information

Poultry Disease Manual Characteristics And

Poultry Disease Manual Characteristics And Poultry Disease Manual Characteristics And Control Of Infections Written by: Dr. Jacquie Jacob, University of Kentucky Pullorum disease, also called Infection by Salmonella pullorum has also been reported

More information

Discussion by HMPC Drafting Group on Quality September Start of public consultation 15 February 2013

Discussion by HMPC Drafting Group on Quality September Start of public consultation 15 February 2013 1 2 3 15 January 2013 EMA/HMPC/13658/2013 Committee on Herbal Medicinal Products (HMPC) 4 5 6 7 Concept paper on use of recovered/recycled solvents in the manufacture of herbal preparations for use in

More information

Anja Holm Danish Medicines Agency. Genetic vaccines Oslo, 2008

Anja Holm Danish Medicines Agency. Genetic vaccines Oslo, 2008 Anja Holm Danish Medicines Agency Genetic vaccines Oslo, 2008 Legal basis for authorisation Special double environmental assessment Authorised GMO products Anja Holm - GMO vaccines - Oslo 2008 2 Regulation

More information

Beurteilungsbericht zur Veröffentlichung. (gemäß 31 Abs. 2 Tierimpfstoff-Verordnung) Poulvac IB Primer

Beurteilungsbericht zur Veröffentlichung. (gemäß 31 Abs. 2 Tierimpfstoff-Verordnung) Poulvac IB Primer Beurteilungsbericht zur Veröffentlichung (gemäß 31 Abs. 2 Tierimpfstoff-Verordnung) Zulassungsdatum: 06.03.2000 Zulassungsnummer: 167a/88 Datum der Erstellung des öffentlichen Beurteilungsberichts: 15.05.2013

More information

THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS

THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS Prepared at the 39th JECFA (1992), published in FNP 52 Add 1 (1992). Metals and arsenic specifications revised at

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax RCP lyophilisate and solvent for suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL

More information

This paper is in two Sections (A and B) and instructions relating to the number of questions to be answered are given at the head of each Section.

This paper is in two Sections (A and B) and instructions relating to the number of questions to be answered are given at the head of each Section. TUESDAY 28 MARCH 2000 PAPER I (3 hours) This paper is in two Sections (A and B) and instructions relating to the number of questions to be answered are given at the head of each Section. SECTION A Two

More information

OIE Influenza Standards and Communication on Pandemic (H1N1) 2009

OIE Influenza Standards and Communication on Pandemic (H1N1) 2009 OIE Influenza Standards and Communication on Pandemic (H1N1) 2009 AVIAN INFLUENZA: INTERSECTORAL COLLABORATION Larnaca, Cyprus 20 22 July 2009 Kate Glynn DVM, MPVM Scientific and Technical Department WORLD

More information

3. Antibody to PPRS Virus (PRRSV) 4. Antibody to Pseudorabies Virus /gpl Aujeszky s Disease (PRV/ADV gpl) 5. Antibody to Swine Salmonella

3. Antibody to PPRS Virus (PRRSV) 4. Antibody to Pseudorabies Virus /gpl Aujeszky s Disease (PRV/ADV gpl) 5. Antibody to Swine Salmonella 1 Swine Serum 1. Antibody to Porcine BioChek, Smart veterinary diagnostics, Circovirus Virus Type 2 (PCV2) Product Code SK105 PCV2 Indirect Enzyme- Linked Immunosorbent Assay 2. Antibody to Classical Swine

More information

Title Revision n date

Title Revision n date A. THIN LAYER CHROMATOGRAPHIC TECHNIQUE (TLC) 1. SCOPE The method describes the identification of hydrocortisone acetate, dexamethasone, betamethasone, betamethasone 17-valerate and triamcinolone acetonide

More information

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS December 2009 ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) This monograph was adopted at the Forty-fourth WHO Expert Committee on Specifications for Pharmaceutical

More information

CONVENTIONAL VACCINE DEVELOPMENT

CONVENTIONAL VACCINE DEVELOPMENT CONVENTIONAL VACCINE DEVELOPMENT PROBLEM Lethal germ Dead mouse LIVE VACCINES Related but harmless germ gives protection against lethal pathogen. Examples are the original pox vaccine and some TB vaccines

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL

More information

Homeopathic medicinal products: an Update

Homeopathic medicinal products: an Update Homeopathic medicinal products: an Update Mag. Dr. Astrid Obmann Expert Group Herbal Medicinal Products & Homeopathics AGES-Gespräch Homeopathics: an Update Vienna, 12.5.2015 www.basg.gv.at Österreichische

More information

5th Conference of the O.I.E. Regional Commission for Africa. The incidence of avian diseases in Africa*

5th Conference of the O.I.E. Regional Commission for Africa. The incidence of avian diseases in Africa* Rev. sci. tech. Off. int. Epiz., 1983, 2 (3), 893-900. 5th Conference of the O.I.E. Regional Commission for Africa Nairobi (Kenya), 18-21 January 1983 The incidence of avian diseases in Africa* Summary

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) European Medicines Agency Veterinary Medicines and Inspections London, 16 February 2006 Doc. Ref.EMEA/CVMP/IWP/46853/2006 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REFLECTION PAPER: MINIMUM

More information

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution August 2015 Draft document for comment 1 2 3 4 5 6 Draft monograph for inclusion in The International Pharmacopoeia Dextromethorphani solutionum peroralum - Dextromethorphan oral solution (August 2015)

More information

Federal Department of Home Affairs FDHA. Federal Food Safety and Veterinary Office FSVO Animal Health

Federal Department of Home Affairs FDHA. Federal Food Safety and Veterinary Office FSVO Animal Health Animal health statistics for 2017 The obligation to report diseases and suspected disease symptoms is laid down in Article 11 of the Swiss Animal Diseases Act (TSG, CC (Classified Compilation) 916.40)

More information

Legal Requirements for the Control of Contaminants in Herbal Medicinal Products and Related Areas

Legal Requirements for the Control of Contaminants in Herbal Medicinal Products and Related Areas Legal Requirements for the Control of Contaminants in Herbal Medicinal Products and Related Areas AOAC International Workshop Erlangen, 11 October 2011 Dr. Barbara Steinhoff Contents Heavy metals Microorganisms

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax RCP FeLV lyophilisate and solvent for suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

Satora Sera rei tat. Disease Cards - Cut Along the Dotted Lines You Make Me Sick!

Satora Sera rei tat. Disease Cards - Cut Along the Dotted Lines You Make Me Sick! Satora Sera rei tat 1 2 3 Common Cold The common cold is caused by a virus. What is a virus? 50 Common Cold The virus that causes the common cold infects the lungs. What are the symptoms of a cold? 50

More information

Discussion by HMPC Drafting Group on Quality February Start of public consultation 27 June 2012

Discussion by HMPC Drafting Group on Quality February Start of public consultation 27 June 2012 1 2 3 22 May 2012 EMA/HMPC/312890/2012 Committee on Herbal Medicinal Products (HMPC) 4 5 6 7 8 Concept paper on non-pharmacopoeial reference standards for herbal substances, herbal preparations and herbal

More information

SUMMARY OF ANTIMICROBIAL ACTIVITY

SUMMARY OF ANTIMICROBIAL ACTIVITY SUMMARY OF ANTIMICROBIAL ACTIVITY ANIMAL FACILITY CONCENTRATED DISINFECTANT CLEANER & DEODORIZER Cleaner Disinfectant Virucide* Description Animal Facility Concentrated Disinfectant is a broad spectrum,

More information

LABORATORY SERVICES. Veterinary Laboratory. Diagnostics Quality Control Research & Development

LABORATORY SERVICES. Veterinary Laboratory. Diagnostics Quality Control Research & Development LABORATORY SERVICES Veterinary Laboratory Diagnostics Quality Control Research & Development BREEDING FOR SUCCESS TOGETHER Antibody Detection Adeno virus: Adeno 127 (EDS) Fowl Adeno Virus (FAdV) Haemorrhagic

More information

Vaccinations, Funding & Goals

Vaccinations, Funding & Goals Animal Transport Best Practices Part V: Animal Transport: Vaccinations, Funding & Goals Presenters David Williams Senior V.P. and COO Michigan Humane Society Dwilliams@michiganhumane.org Martha Boden CEO

More information

THERMALLY OXIDIZED SOYA BEAN OIL

THERMALLY OXIDIZED SOYA BEAN OIL THERMALLY OXIDIZED SOYA BEAN OIL Prepared at the 39th JECFA (1992), published in FNP 52 Add 1 (1992). Metals and arsenic specifications revised at the 55th JECFA (2000). An ADI of 0-3 mg/kg bw was established

More information

Agencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State)

Agencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State) DEPARTAMENTO DE MEDICAMENTOS VETERINARIOS Medicamentos y Productos C/Campezo 1, Edificio 8 28022 Madrid España (Reference Member State) MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT

More information

Animal Disease Reporting for the month March 2018

Animal Disease Reporting for the month March 2018 Animal Disease Reporting for the month March 2018 Sub-Directorate Epidemiology Directorate Animal Health 23 May 2018 Introduction According to the Animal Diseases Act, 1984 (Act 35 of 1984) Controlled

More information

Use of OIE standards for international trade. Content of the presentation

Use of OIE standards for international trade. Content of the presentation REGIONAL SEMINAR FOR RECENTLY APPOINTED OIE DELEGATES BRUSSELS / BELGIUM FEBRUARY 2014 Use of OIE standards for international trade Content of the presentation Official status self declaration disease

More information

Good pharmacopoeial practices: Chapter on monographs on herbal medicines

Good pharmacopoeial practices: Chapter on monographs on herbal medicines Annex 7 Good pharmacopoeial practices: Chapter on monographs on herbal medicines Background Following the fiftieth meeting of the WHO Expert Committee on Specifications for Pharmaceutical Preparations,

More information

BRITISH PHARMACOPOEIA COMMISSION EXPERT ADVISORY GROUP: MEDICINAL CHEMICALS 3 SUMMARY MINUTES

BRITISH PHARMACOPOEIA COMMISSION EXPERT ADVISORY GROUP: MEDICINAL CHEMICALS 3 SUMMARY MINUTES BRITISH PHARMACOPOEIA COMMISSION EXPERT ADVISORY GROUP: MEDICINAL CHEMICALS 3 SUMMARY MINUTES A meeting of Expert Advisory Group (EAG): Medicinal Chemicals 3 (MC3) was held at 151 Buckingham Palace Road,

More information

Guideline on quality aspects on the isolation of candidate influenza vaccine viruses in cell culture

Guideline on quality aspects on the isolation of candidate influenza vaccine viruses in cell culture 11 July 2011 EMA/CHMP/BWP/368186/2011 Committee for Human Medicinal Products (CHMP) Guideline on quality aspects on the isolation of candidate influenza vaccine viruses in Draft Agreed by Biologics Working

More information

MCQS ON LIPIDS. Dr. RUCHIKA YADU

MCQS ON LIPIDS. Dr. RUCHIKA YADU MCQS ON LIPIDS Dr. RUCHIKA YADU Q1. THE FATS AND OILS ARE RESPECTIVELY RICH IN a) Unsaturated fatty acids b) Saturated fatty acids c) Saturated and unsaturated fatty acids d) None of these Q2. ESSENTIAL

More information

Fresh Citrus Disinfectant Cleaner

Fresh Citrus Disinfectant Cleaner SUMMARY OF ANTIMICROBIAL ACTIVITY Fresh Citrus Disinfectant Cleaner Description Fresh Citrus Disinfectant Cleaner is an effective economical 4 ounce per gallon disinfectant, specifically designed for hospitals,

More information

Multiplex analysis of avian respiratory viruses

Multiplex analysis of avian respiratory viruses Multiplex analysis of avian respiratory viruses Gordon Kirby () & Davor Oykitch (AHL) Animal Health Laboratory U of Guelph OMAFRA Practitioners & Producers Public Health Other Universities CFIA AHL Caseload

More information

Guideline on quality of herbal medicinal products 1 /traditional herbal medicinal products

Guideline on quality of herbal medicinal products 1 /traditional herbal medicinal products 31 March 2011 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) Committee on Herbal Medicinal Products (HMPC) Guideline on quality of herbal

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL

More information

Official Journal of the European Union REGULATIONS

Official Journal of the European Union REGULATIONS 8.10.2016 L 273/5 REGULATIONS COMMISSION IMPLEMTING REGULATION (EU) 2016/1784 of 30 September 2016 amending Regulation (EEC) No 2568/91 on the characteristics of olive oil and olive-residue oil and on

More information

The Scientific Relevance of the ATT Today and from a historical Perspective

The Scientific Relevance of the ATT Today and from a historical Perspective www.pei.de The Scientific Relevance of the ATT Today and from a historical Perspective Dr. Klaus Cussler EPAA International Workshop Towards global harmonization of 3Rs in biologicals 15-16 September 2015

More information

The International Pharmacopoeia - Overview

The International Pharmacopoeia - Overview The International Pharmacopoeia - Overview Caroline Mendy - Technical Officer Quality Assurance and Safety: Medicines World Health Organization 1 The International Pharmacopoeia Ph. Int. Scope WHO Consultative

More information

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1)

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1) INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Eurican DAPPi lyophilisate and solvent for suspension for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

Revisions to USP 30 NF 25, Second Supplement

Revisions to USP 30 NF 25, Second Supplement Revisions to USP 30 NF 25, Second Supplement Published June 2007 General Chapters Monographs: A C D N O S T Z Monograph Monograph Section Scientific Liaison USP Reference standards Dissolution, Procedure

More information

Differential Diagnosis of Respiratory Disease in Broilers

Differential Diagnosis of Respiratory Disease in Broilers UD Poultry Health System(Lasher and Allen Labs) Department of Animal & Food Sciences College of Agriculture and Natural Resources University of Delaware Newark, DE 19717-1303 USA Differential Diagnosis

More information

Livestock Diagnostic Products for Poultry. Kylt Professional in vitro Diagnostic Solutions.

Livestock Diagnostic Products for Poultry. Kylt Professional in vitro Diagnostic Solutions. Livestock Diagnostic s for Poultry Kylt Professional in vitro Diagnostic Solutions www.kylt.eu 2017 Kylt Livestock Diagnostic s for Poultry The Kylt products are designed for rapid and precise pathogen

More information

BRIEFING. Nonharmonized attributes: Identification, Heavy metals, Characters, Labeling, Bacterial endotoxins, Sterility, Storage.

BRIEFING. Nonharmonized attributes: Identification, Heavy metals, Characters, Labeling, Bacterial endotoxins, Sterility, Storage. BRIEFING Citric Acid, Anhydrous, page 872 of PF 28(3) [May June 2002]. The European Pharmacopoeia is the coordinating pharmacopeia for the international harmonization of the compendial standards for the

More information

Scientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation

Scientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation Scientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation Dr. Frauke Gaedcke, Waidesch Dr. Barbara Steinhoff, Konigswinter In collaboration with Dr. Helga Blasius,

More information

Ceva HAND book of poultry diseases

Ceva HAND book of poultry diseases IVAN DINEV & CEVA Volume 1 Ceva HAND book of poultry diseases GUMBORO CHICKEN ANaEMIA REOVIRUS MAREK RUNTING-STUNTING SYNDROME NEWCASTLe DISEASE AVIAN INFLUENZA INFECTIOUS BRONCHITIS LARyNGOTRACHEITIS

More information

SUMMARY MINUTES. of the BRITISH PHARMACOPOEIA COMMISSION

SUMMARY MINUTES. of the BRITISH PHARMACOPOEIA COMMISSION SUMMARY MINUTES of the BRITISH PHARMACOPOEIA COMMISSION A meeting of the was held at 151, Buckingham Palace Road, London SW1W 9SZ on Monday 22 nd September 2014. Present: Professor K Taylor (Chair), Professor

More information

OIE Collaborating Centres Reports Activities

OIE Collaborating Centres Reports Activities OIE Collaborating Centres Reports Activities Activities in 2017 This report has been submitted : 2018-02-08 16:56:40 Title of collaborating centre: Quality Control of Veterinary Vaccines Address of Collaborating

More information

Public Assessment Report Scientific discussion

Public Assessment Report Scientific discussion Public Assessment Report Scientific discussion Hypermin, tablet [Hypericum perforatum L., (St. John s wort) herba recens, dry extract (3.1-4.0:1) ethanol 60 %] Asp. no: 2008-1034 This module reflects the

More information

ANSES. Agence Nationale du Médicament Vétérinaire (National Agency for Veterinary Drugs) (Reference Member State) BP FOUGERES CEDEX FRANCE

ANSES. Agence Nationale du Médicament Vétérinaire (National Agency for Veterinary Drugs) (Reference Member State) BP FOUGERES CEDEX FRANCE ANSES Agence Nationale du Médicament Vétérinaire (National Agency for Veterinary Drugs) (Reference Member State) BP 90203 35302 FOUGERES CEDEX FRANCE DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT

More information

How To... Take FTA Card Samples

How To... Take FTA Card Samples How To... What is an FTA card? FTA (Flinders Technology Associates) cards are cottonbased, cellulose paper containing chemicals that burst cells, denature proteins and protect DNA, leaving a sample suitable

More information

ONE STEP (Lemon, Mint, Pine) Detergent for Cleaning, Disinfecting and Deodorizing

ONE STEP (Lemon, Mint, Pine) Detergent for Cleaning, Disinfecting and Deodorizing SUMMARY OF ANTIMICROBIAL ACTIVITY ONE STEP (Lemon, Mint, Pine) Detergent for Cleaning, Disinfecting and Deodorizing Description One Step is an effective economical 4 ounce per gallon disinfectant, specifically

More information

MONOGRAPHS (NF) Pharmacopeial Forum 616 HARMONIZATION Vol. 31(2) [Mar. Apr. 2005]

MONOGRAPHS (NF) Pharmacopeial Forum 616 HARMONIZATION Vol. 31(2) [Mar. Apr. 2005] 616 HARMONIZATION Vol. 31(2) [Mar. Apr. 2005] the recorder. The substances are eluted in the following order: o-toluenesulfonamide, p-toluenesulfonamide, and caffeine. The test is not valid unless the

More information

STANDARD FOR CREAM AND PREPARED CREAMS

STANDARD FOR CREAM AND PREPARED CREAMS 1 Codex Standard 288-1976 STANDARD FOR CREAM AND PREPARED CREAMS CODEX STAN 288-1976 1. SCOPE This Standard applies to cream and prepared creams for direct consumption or further processing as defined

More information

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010) June 2010 TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010) This monograph was adopted at the Forty-fourth WHO Expert Committee on Specifications for Pharmaceutical

More information

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. # Inc. Efficacy: Hospital Disinfection (at ½ ounce per gallon) Kennel Kare SC is bactericidal according to the AOAC Use Dilution Test method on hard inanimate surfaces modified in the presence of 5% organic

More information

CODEX STANDARD FOR CREAM AND PREPARED CREAMS

CODEX STANDARD FOR CREAM AND PREPARED CREAMS CODEX STANDARD FOR CREAM AND PREPARED CREAMS CODEX STAN 288-1976 1. SCOPE This Standard applies to cream and prepared creams for direct consumption or further processing as defined in Section 2 of this

More information

DISEASES OF CHICKENS AND TURKEYS CORRELATED WITH AGE

DISEASES OF CHICKENS AND TURKEYS CORRELATED WITH AGE By knowing the species affected, salient clinical feature, and age of the flock, it is often possible to make a list of potential differential diagnoses. In the following table, some of the more common

More information

State Pharmacopoeia of Ukraine

State Pharmacopoeia of Ukraine State Pharmacopoeia of Ukraine WHO INTERNATIONAL MEETING OF WORLD PHARMACOPOEIAS 29.02 2.03 2012 Geneva, Executive Board Room Oleksandr Gryzodub Director of «Ukrainian Scientific Pharmacopoeial Center

More information

Veterinary Vaccines and Their Importance to Animal Health and Public Health

Veterinary Vaccines and Their Importance to Animal Health and Public Health Veterinary Microbiology and Preventive Medicine Publications Veterinary Microbiology and Preventive Medicine 2011 Veterinary Vaccines and Their Importance to Animal Health and Public Health James A. Roth

More information

HEPARIN SODIUM. Heparinum natricum

HEPARIN SODIUM. Heparinum natricum Pharmeuropa 25.1 1 Reference: PA/PH/Exp. 6/T (12) 37 ANP NOTE ON THE MONOGRAPH Definition. It is proposed to restrict the scope to heparin material of porcine origin since some of the latest requirements

More information

Official Journal of the European Union L 40/19

Official Journal of the European Union L 40/19 11.2.2009 Official Journal of the European Union L 40/19 COMMISSION DIRECTIVE 2009/8/EC of 10 February 2009 amending Annex I to Directive 2002/32/EC of the European Parliament and of the Council as regards

More information

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION SCIENTIFIC DISCUSSION 1. SUMMARY OF THE DOSSIER Nobilis Influenza H5N2 emulsion for injection, is an adjuvanted, inactivated vaccine against avian influenza type A, subtype H5 in chickens. Avian influenza

More information

Regulation of FMD vaccines within the European Union

Regulation of FMD vaccines within the European Union Introduction Regulation of FMD vaccines within the European Union K De Clercq 1 and D K J Mackay 2 Appendix 36 The EUFMD European Pharmacopoeia Working Group made a proposal for revision of the FMD vaccine

More information

Health Products Regulatory Authority

Health Products Regulatory Authority 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis ND Clone 30 live 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: per dose * Live Newcastle disease virus, strain Clone 30 ³ 6.0 log 10 ELD

More information

European Union legislation on Food additives, Food enzymes, Extractions solvents and Food flavourings

European Union legislation on Food additives, Food enzymes, Extractions solvents and Food flavourings European Union legislation on Food additives, Food enzymes, Extractions solvents and Food flavourings European Commission, DG, Unit E3 Chemicals, contaminants and pesticides Serbia-Screening meeting on

More information

Final text for addition to The International Pharmacopoeia (June 2010)

Final text for addition to The International Pharmacopoeia (June 2010) June 2010 KANAMYCIN ACID SULFATE: Final text for addition to The International Pharmacopoeia (June 2010) This monograph was adopted at the Forty-fourth WH Expert Committee on Specifications for Pharmaceutical

More information

Development of Genotoxic Impurities Control in Active Pharmaceutical Ingredient

Development of Genotoxic Impurities Control in Active Pharmaceutical Ingredient ( 322002) (active pharmaceutical ingredient API) R284.1 A 1007-7693(2015)01-0119-08 DOI: 10.13748/j.cnki.issn1007-7693.2015.01.032 Development of Genotoxic Impurities Control in Active Pharmaceutical Ingredient

More information

Recommended Resources: The following resources may be useful in teaching this

Recommended Resources: The following resources may be useful in teaching this Unit C: Poultry Management Lesson 3: Poultry Health Management Student Learning Objectives: Instruction in this lesson should result in students achieving the following objectives: 1. Demonstrate sanitation

More information

GSC CODEX MESSAGE CCFH42/2011/27 Codex Committee on Food Hygiene (43 rd Session) Miami (5-9 December 2011)

GSC CODEX MESSAGE CCFH42/2011/27 Codex Committee on Food Hygiene (43 rd Session) Miami (5-9 December 2011) GSC CODEX MESSAGE CCFH42/2011/27 Codex Committee on Food Hygiene (43 rd Session) Miami (5-9 December 2011) EU comments on the Proposed Draft Guidelines on the Application of General Principles of Food

More information

REPORTABLE AND NOTIFIABLE DISEASES REGULATION

REPORTABLE AND NOTIFIABLE DISEASES REGULATION Province of Alberta ANIMAL HEALTH ACT REPORTABLE AND NOTIFIABLE DISEASES REGULATION Alberta Regulation 209/2008 With amendments up to and including Alberta Regulation 10/2014 Office Consolidation Published

More information

Pharmacopeial Forum 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA

Pharmacopeial Forum 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA Following is a list of errata and corrections to USP NF. The page number indicates where the item is found and in which official or

More information

Methotrexate. (Ph. Eur. monograph 0560) C 20 H 22 N 8 O Action and use. Dihydrofolate reductase inhibitor; cytostatic.

Methotrexate. (Ph. Eur. monograph 0560) C 20 H 22 N 8 O Action and use. Dihydrofolate reductase inhibitor; cytostatic. Browse: British Pharmacopoeia 2013 British Pharmacopoeia Volume I & II Monographs: Medicinal and Pharmaceutical Substances Methotrexate Methotrexate General Notices (Ph. Eur. monograph 0560) C 20 H 22

More information

Veterinary vaccines and their importance to animal health and public health

Veterinary vaccines and their importance to animal health and public health Available online at www.sciencedirect.com Procedia in Vaccinology 5 (2011) 127 136 NICEATM-ICCVAM # International Workshop on Alternative Methods to Reduce, Refine, and Replace the Use of Animals in Vaccine

More information

Fraser Menzies Veterinary Epidemiology Unit DARD

Fraser Menzies Veterinary Epidemiology Unit DARD Fraser Menzies Veterinary Epidemiology Unit DARD Photos from: http://www.50pluslife.com/2015/08/04/highly-pathogenic-avian-influenza-what-does-it-mean-for-city-dwellers/ HPAI Avian flu outbreaks in domestic

More information

BIOB111_CHBIO - Tutorial activity for Session 12

BIOB111_CHBIO - Tutorial activity for Session 12 BIOB111_CHBIO - Tutorial activity for Session 12 General topic for week 6 Session 12 Lipids Useful Links: 1. Animations on Cholesterol (its synthesis, lifestyle factors, LDL) http://www.wiley.com/college/boyer/0470003790/animations/cholesterol/cholesterol.htm

More information

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015) August 2015 Document for comment 1 2 3 4 5 CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA (AUGUST 2015) DRAFT FOR COMMENT 6 Should you have any comments

More information

Export Requirements Notification - Animal Products Act Standards Branch, Animal and Animal Products Directorate, Ministry for Primary Industries

Export Requirements Notification - Animal Products Act Standards Branch, Animal and Animal Products Directorate, Ministry for Primary Industries Export Requirements Notification - Animal Products Act 1999 Standards Branch, Animal and Animal Products Directorate, Ministry for Primary Industries Ref: AE-TH-19L Date: 15 May 2013 BIRAVIEC.TH 22 MAY

More information

Campylobacter work at the UK Veterinary Laboratories Agency

Campylobacter work at the UK Veterinary Laboratories Agency Campylobacter work at the UK Veterinary Laboratories Agency Monique Toszeghy CRL Workshop for Campylobacter SVA, Uppsala, Sweden 24 th October 2006 History of VLA 1894 - a forerunner to the Central Veterinary

More information

ANNOTATED LIST. Monographs, General Chapters, Reagents, and Tables Affected by Changes Appearing in This Supplement

ANNOTATED LIST. Monographs, General Chapters, Reagents, and Tables Affected by Changes Appearing in This Supplement 8506 Annotated List Second Supplement to USP 40 NF 35 ANNOTATED LIST Monographs, General Chapters, Reagents, and Tables Affected by Changes Appearing in This Supplement Page citations refer to the pages

More information

Avian Infectious Bronchitis Vaccine, Inactivated

Avian Infectious Bronchitis Vaccine, Inactivated Avian Infectious Bronchitis Vaccine, Inactivated Avian Infectious Bronchitis Vaccine, Inactivated consists of an emulsion or a suspension of one or more serotypes of avian infectious bronchitis virus which

More information

» Monohydrate Citric Acid contains one molecule of water of hydration. It contains not less than 99.5 percent and not more than 100.

» Monohydrate Citric Acid contains one molecule of water of hydration. It contains not less than 99.5 percent and not more than 100. BRIEFING Citric Acid, Monohydrate. The European Pharmacopoeia is the coordinating pharmacopeia for the international harmonization of the compendial standards for the Citric Acid, Monohydrate monograph,

More information

ENCEFAL-VAC SUMMARY OF PRODUCT CHARACTERISTICS

ENCEFAL-VAC SUMMARY OF PRODUCT CHARACTERISTICS ENCEFAL-VAC SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ENCEFAL-VAC Live lyophilised vaccine for chickens 2. QUALITATIVE AND QUANTITATIVE

More information

Lipids and Membranes

Lipids and Membranes Lipids Lipids are hydrophobic or amphiphilic insoluble in water soluble in organic solvents soluble in lipids Lipids are used as energy storage molecules structural components of membranes protective molecules

More information

MONOGRAPHS (USP) Saccharin Sodium

MONOGRAPHS (USP) Saccharin Sodium Vol. 31(4) [July Aug. 2005] HARMONIZATION 1225 MONOGRAPHS (USP) BRIEFING Saccharin Sodium, USP 28 page 1745 and page 612 of PF 31(2) [Mar. Apr. 2005]. The United States Pharmacopeia is the coordinating

More information

Comments were received for the following when they were proposed in the Food Chemicals Codex Forum (FCCF):

Comments were received for the following when they were proposed in the Food Chemicals Codex Forum (FCCF): Comments were received for the following when they were proposed in the Food Chemicals Codex Forum (FCCF): Monographs: Allyl Mercaptan Beta-Carotene Bisabolene Butyl Stearate Glycine Insoluble Foreign

More information